This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Therapy
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studies. SVHA
British Journal of Clinical Pharmacology:2022: February 1 Full text
Clinical Practice
Telehealth cancer care consultations during the COVID-19 pandemic: a qualitative study of the experiences of Australians affected by cancer. AUS
Supportive Care in Cancer:2022: May 3 Full text
Pathophysiology
Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study.
Lancet Regional Health – Americas: 2022: June 16 Full text
Outcomes of SARS-CoV-2 reinfection
Research Square:2022: June 17 Full text
Infection Control
SARS-CoV-2 transmission risk to healthcare workers performing tracheostomies: a systematic review.
ANZ Journal of Surgery:2022: June 2 Full text
Vaccines
Effects of previous infection and vaccination on symptomatic Omicron infections.
New England Journal of Medicine:2022: June 15 Full text
Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study.
BMJ:2022: May 5 Full text
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
New England Journal of Medicine:2022: June 22 Full text
Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease.
Cardiovascular Research:2022: June 20 Full text
Immunology
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
Nature:2022: June 17 Full text
Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection.
Lancet Infectious Diseases: 2022: June 20 Full text
SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.
International Journal of Infectious Diseases:2022: June 18 Full text
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection.
Cell Reports Medicine:2022: June 20 Full text
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.
Cell Reports Medicine:2022: June 20 Full text
